Latest news with #DallahHealthcare
Argaam
06-08-2025
- Business
- Argaam
Dallah's Al-Ahsa, Al-Khobar hospitals to add over SAR 500M to 2025 topline: CEO
Tarek Alkasabi, CEO of Dallah Healthcare Co., said the outlook for the third quarter and beyond is very optimistic, pointing to broad areas for potential growth, especially after recent acquisitions. In an interview with Argaam, the top executive expected Dallah's recently-acquired Al-Khobar and Al-Ahsa hospitals to contribute more than SAR 500 million to revenues in 2025 (starting from their acquisition date). This uptrend should persist at high rates in the following years, in tandem with increased occupancy rates at both hospitals, especially Dallah Hospital Al-Khobar, he further stated. In Q2 2025, Dallah's topline increased by 38.8% year-on-year (YoY), exceeding the SAR 1 billion mark for the first time in the Saudi-listed company's history. This came thanks to elevated operational capacity and strategic expansions undertaken by the group, both being carried out at existing and recently-acquired medical facilities. This in turn has bolstered the growth momentum in patient visits, according to the CEO. The March 23 acquisition of Al Salam Medical Services Co., which owns Dallah Hospital Al-Khobar, and Al Ahsa Medical Services Co., owner of Dallah Hospital Al-Ahsa, reflected positively on higher revenues. Prior to this takeover, existing medical facilities had posted a YoY revenue hike of about SAR 121 million (or 15.8%), he highlighted. Commenting on the impact of Dallah's ongoing expansions on operating margins, Alkasabi said it is only normal for margins to be slightly hit for a relatively short period, especially since Dallah Hospital Al-Khobar is still in its early stages of operation. He also clarified that operating expenses may top the benchmark average, albeit the two hospitals have already begun to see improved operating margins during the second quarter of this year. This uptrend is likely to prevail going forward, bringing margins on par with the rest of the group's facilities. As for Dallah's planned expansions, the coming period will see more focus on expanding Dallah Hospital Al-Khobar through the addition of new clinics, beds, and specialities. At present, the hospital encompasses 150 beds. The goal is to bring the full run rate at more than three times its current bed capacity, or about 475 beds. This would translate into a group-wide operating capacity of over 1,900 beds, and a total of 2,560 beds when factoring in those of associates, according to the CEO. Regarding the quantitative impact of recent expansions, Alkasabi stated that the acquisition of Dallah Hospital Al-Ahsa and Dallah Hospital Al-Khobar boosted the group's operational capacity by 37%, adding 424 beds (274 in Al-Ahsa and 150 in Al-Khobar). He expects this percentage to reach 65% when the Al-Khobar hospital hits its full run rate. In Q2 2025, Dallah witnessed a notable YoY surge in patient visits. At existing facilities, the footfall accelerated by 14%, particularly after the latest expansions (mainly the operation of the Dallah Hospital Namar expansion project). Alkasabi also pointed to a potentially deeper influence from the recent hospital acquisitions, through which the total number of patient visits to all Dallah medical facilities increased by nearly 44%.
Zawya
06-08-2025
- Business
- Zawya
Saudi: Dallah Healthcare unveils $74.66mln profits in H1-25, dividends for Q2
Riyadh - Dallah Healthcare Company generated net profits valued at SAR 279.82 million in the first half (H1) of 2025, up 21.05% year-on-year (YoY) from SAR 231.14 million. Revenues amounted to SAR 1.89 billion as of 30 June 2025, an annual rise of 22.33% from SAR 1.54 billion, according to the financial results. The earnings per share (EPS) climbed to SAR 2.81 in H1-25 from SAR 2.37 a year earlier. Results for Q2-25 In the second quarter (Q2) of 2025, the company recorded 11.10% higher net profits at SAR 124.26 million, compared to SAR 111.84 million in Q2-24. The revenues jumped by 38.84% YoY to SAR 1.06 billion during April-June 2025 from SAR 765.18 million. Quarterly, the Q2-25 profits plunged by 20.12% from SAR 155.56 million in January-March 2025, while the revenues increased by 27.58% from SAR 832.75 million. Dividends for Q2-25 The board approved cash dividends valued at SAR 50.59 million to 86 million eligible shares for Q2-25. The medical group will distribute SAR 0.50 per share, representing 5% of the share's nominal value. Eligibility and payment dates for the dividends will be 17 August and 4 September, respectively. All Rights Reserved - Mubasher Info © 2005 - 2025 Provided by SyndiGate Media Inc. (
Arab News
12-07-2025
- Business
- Arab News
SAB signs on as mentor in ministry's sustainability program
SAB will mentor a select group of prominent organizations, including Dallah Healthcare Company, Rawabi Holding Company, Middle East Paper Company, and City Cement Company. Saudi Awwal Bank, one of the leading banks in the Kingdom, has announced its participation in the Ministry of Economy and Planning's Sustainability Champions Program. The official signing ceremony took place on May 28 at SAB Tower, marking a key milestone in SAB's commitment to sustainability. The MEP Sustainability Champions Program aims to enhance sustainability performance across key sectors by partnering with organizations that demonstrate leadership and a commitment to sustainable practices. As a mentor in the program, SAB will utilize its extensive experience and resources to support and guide its mentees on their sustainability journeys. As part of its role, SAB will mentor a select group of prominent organizations in the program, including Dallah Healthcare Company, Rawabi Holding Company, Middle East Paper Company, and City Cement Company. This initiative marks the beginning of a collaborative effort to enhance sustainability practices across key sectors and achieve Vision 2030 goals. Tony Cripps, managing director of SAB, said: 'Sustainability is no longer a choice — it's a responsibility. Through our partnership with the MEP Sustainability Champions Program, SAB is taking tangible steps to build the knowledge infrastructure around sustainability and contribute to the Kingdom's goals. We are proud to be part of this forward-looking initiative, which aligns with our environmental, social and governance strategy and our commitment to supporting sustainable economic growth.' The signing ceremony marked the beginning of a strategic collaboration focused on sustainability. Senior executives from SAB and the participating mentees attended the event, emphasizing the shared commitment to advancing sustainability across key sectors. SAB continues to demonstrate its leadership in sustainability through its comprehensive ESG strategy. The bank is actively engaged in various initiatives that foster sustainable economic development in line with Saudi Vision 2030. Through its partnerships with governmental bodies, such as the Ministry of Economy and Planning, SAB plays a key role in driving forward the Kingdom's sustainability aspirations, contributing to long-term, positive environmental and societal impacts.
Argaam
27-05-2025
- Business
- Argaam
Dallah plans 622,450 share buyback for employee incentive program
Dallah Healthcare Co.'s (Dallah Health) board of directors recommended the buyback of a maximum of 622,450 shares, to be allocated for the employee stock incentive program (ESIP), according to a statement to Tadawul today, May 27. The repurchase will be financed through Dallah's own resources, as it holds 0.37% of treasury shares. Dallah added that it will seek approval for the buyback process during the next extraordinary general meeting (EGM), as required by Paragraph 4 of Article 17 of the Executive Regulations of the Companies Law for Listed Joint Stock Companies. Additionally, the company affirmed that it will comply with the solvency requirements outlined in Paragraph 3 of Article 17 of the same regulations. Dallah also noted that the repurchased shares will not have voting rights in the shareholders' assemblies. The company currently holds 377,550 shares as treasury shares, which were originally repurchased to be retained as treasury shares. It aims to potentially utilize them in future swap transactions for acquiring shares or stakes in a company or for purchasing an asset. The board of directors recommended changing the purpose of these shares to be allocated to the ESIP. This change will be presented to the EGM for approval. As a result, the total number of shares allocated to the ESIP will reach one million shares, assuming the company proceeds with purchasing the maximum number of shares mentioned in the announcement above, in addition to changing the purpose of the 377,550 shares shares currently held as treasury shares.
Zawya
16-05-2025
- Business
- Zawya
Saudi: Dallah Healthcare's net profits grow 30% in Q1-25
Riyadh - Dallah Healthcare Company reported 30.39% higher net profits at SAR 155.56 million in the first quarter (Q1) of 2025, compared to SAR 119.30 million in Q1-24. The earnings per share (EPS) stood at SAR 1.59 as of 31 March 2025, marking a 30% hike from SAR 1.22 in Q1-24, as per the financial results. Furthermore, the revenues rose by 6.20% year-on-year (YoY) to SAR 832.75 million in the first three months (3M) of 2025 from SAR 784.06 million. Quarter-on-quarter (QoQ), the net profits in Q1-25 soared by 36.57% from SAR 113.90 million in Q4-24, while the revenues increased by 2.96% from SAR 808.76 million. At the end of December 2024, Dallah Healthcare generated an annual rise in net profits to SAR 471.20 million from SAR 360.12 million. All Rights Reserved - Mubasher Info © 2005 - 2022 Provided by SyndiGate Media Inc. (
